The case defi nition for chronic fatigue syndrome was developed for adults (Fukuda et al. 1994) , and this case defi nition may not be appropriate for use with children and adolescents. The lack of application of a consistent pediatric defi nition for this illness and the lack of a reliable instrument to assess it might lead to studies which lack sensitivity and specifi city. In this article, a case defi nition is presented that has been endorsed by the International Association of ME/CFS.
children who are under the age of 18 years old (see http://www.iacfsme.org/Portals/0/pdf/ DePaulPediatricHealthQuestionaire.pdf).
ME/CFS pediatric case defi nition
It is critical that those conducting studies attempting to diagnose children with ME/CFS carry out a thorough evaluation, including a comprehensive medical and developmental history, physical examination, and laboratory tests to confirm diagnosis. The history should involve both the parents as well as the child because children are still constructing their identity.
The defi nition presented has elements of the Fukuda et al. (1994) adult case defi nition, along with the recommendations of Reeves et al. (2003) . We have also incorporated the structure of a new clinical case defi nition for ME/CFS that has been developed in Canada (Carruthers et al. 2003) . We believe that requiring certain symptoms does provide more specifi cation of critical symptoms for a case defi nition. However, we have tried to limit the types of symptoms within each of the Canadian criteria categories to allow investigators to more reliably categorize pediatric patients. We also believe that this case defi nition does reduce the prominence of the symptom fatigue and more explicitly highlights the importance of symptoms such as dizziness, pain, and fl u-like symptoms.
Below we present a pediatric case defi nition for ME/CFS. To be diagnosed with pediatric ME/CFS, the child or adolescent must have clinically evaluated, unexplained, persistent or relapsing chronic fatigue over the past 3 months that is not the result of ongoing exertion; is not substantially alleviated by rest; results in substantial reduction in previous levels of educational, social and personal activities; and must persist or reoccur for at least three months. The three month criteria is in contrast to the six month criteria that exists with the adult Fukuda et al. case defi nition. The Canadian criteria suggest that children with symptoms lasting more than three months duration can be diagnosed with the illness (Carruthers et al. 2004) . We agree with this notion, as Fowler, Duthie, Thapar, and Farmer (2005) did not fi nd differences between 8-17 years olds with 3 versus 6 months of chronic fatigue.
The adult Fukuda et al. (1994) criteria defi nition required that the fatigue not be lifelong and that it be of a new and defi nite onset. We did not use this criterion because children and their families may not be able to pinpoint a defi nite onset. The Fukuda et al. (1994) case defi nition also had the provision that the symptoms such as sore throat or memory impairment not predate the fatigue, but we also did not use this criterion as it has been found that, in children with an insidious onset, such symptoms may in fact predate fatigue.
Critical symptoms
In addition, the children must have the concurrent occurrence of the following classic ME/CFS symptoms, which must have persisted or recurred during the past three months of illness (symptoms may predate the reported onset of fatigue). Support for the inclusion of these symptoms emerged from Rowe and Rowe's (2002) confirmatory factor analysis, which found muscle pain and fatigue, neurocognitive, abdominal, head and chest pain, neurophysiological, and immunological factors. We recommend using the Pediatric ME/CFS Questionnaire, which provides a way of gathering this information to help diagnose pediatric ME/ CFS . It is generally recommended that adolescents age 12 and older fill it out themselves, and parents can assist or fill it out for children 11 and under. Some children might need to complete the questionnaire over several days if this task being completed at one testing might exacerbate the children's symptoms. It is important to rate each symptom for severity and frequency, and to operationalize criteria to meet the case defi nition. Using the question: "how much does this symptom bother you," for a symptom to meet criteria, it should be rated a 4 or higher on the following scale: 1 = no problem, 4 = moderate problem, 7 = big problem. In regard to how often the child has the symptom, to meet criterion, a symptom would have to be rated a 4 or higher on the following scale: 1 = hardly ever, to 4 = half of the time, to 7 = always.
Post-exertional malaise and/or post-exertional fatigue. With activity (it need not be strenuous and may include walking up a fl ight of stairs, or as minimal as using a computer or reading a book), there must be a loss of physical or mental stamina, rapid/sudden muscle or cognitive fatigability, post-exertional malaise and/or fatigue and a tendency for other associated symptoms within the patient's cluster of symptoms to worsen. The recovery is slow, often taking 24 hours or longer.
Unrefreshing sleep or disturbance of sleep quantity or rhythm disturbance. These symptoms may include prolonged sleep (including frequent naps), disturbed sleep (e.g. inability to fall asleep or early awakening), and/or day/night reversal.
Pain (or discomfort). These symptoms are often widespread and migratory in nature. There needs to occur at least one symptom from any of the following: Myofascial and/or joint pain, abdominal and/or head pain. Myofascial pain can include deep pain, muscle twitches, or achy and sore muscles. Pain, stiffness, or tenderness may occur in any joint but must be present in more than one joint and lacking edema or other signs of infl ammation. Children with abdominal and/or head pain may experience eye pain/sensitivity to bright light, stomach pain, nausea, vomiting, or chest pain. People with ME/CFS often describe headaches as localized behind the eyes or in the back of the head, and may include headaches localized elsewhere, including migraines.
The young people must also experience two or more neurocognitive manifestations, which can include: impaired memory (self-reported or observable disturbance in ability to recall information or events on a short-term basis), diffi culty focusing (disturbed concentration may impair ability to remain on task, to screen out extraneous/excessive stimuli in a classroom, or to focus on reading, computer/work activity, or television programs), diffi culty fi nding the right word, frequently forgetting what one wanted to say, absent mindedness, slowness of thought, diffi culty recalling information, need to focus on one thing at a time, trouble expressing thought, diffi culty comprehending information, frequently losing train of thought, or new trouble with math or other educational subjects.
Finally, the child must experience at least one symptom from two of the following three categories: 1. Autonomic manifestations: Neurally mediated hypotension, postural orthostatic tachycardia, delayed postural hypotension, palpitations with or without cardiac arrhythmias, dizziness, feeling unsteady on the feet-disturbed balance, shortness of breath. 2. Neuroendocrine manifestations: Recurrent feelings of feverishness and cold extremities, subnormal body temperature and marked diurnal fl uctuations, sweating episodes, intolerance of extremes of heat and cold, marked weight change-loss of appetite or abnormal appetite, worsening of symptoms with stress. 3. Immune manifestations: Recurrent fl u-like symptoms, non-exudative sore or scratchy throat, repeated fevers and sweats, lymph nodes tender to palpitation-generally minimal swelling noted, new sensitivities to food, odors, or chemicals.
Severe versus moderate categories
We created a separate category for those who met almost all criteria, and they were classifi ed with the Moderate ME/CFS Clinical criteria. These adolescents needed to have 3 or more months of fatigue and needed to report four out of the fi ve classic ME/CFS symptoms with frequency and severity ratings of moderate or severe (a rating of 4 or higher, on a scale of 1-7). In addition, for autonomic, neuroendocrine, and immune manifestations, adolescents had to have at least one symptom in any of these three categories, as opposed to one symptom from two of the three categories.
Other categories
The Pediatric Case Defi nition for ME/CFS also diagnoses children and adolescents with subtype variations of ME/CFS for those who experience idiopathic chronic fatigue. One subtype variation is Atypical ME/CFS, which is defi ned as 3 or more months of fatigue, but missing more than one classic ME/CFS symptoms. It is also possible to receive a diagnosis of ME/CFS in remission, if they met full symptom criteria at one time but were not experiencing full symptomology at the time of the study. Another category involves Pediatric ME/CFS-like illness, which is defi ned as meeting all classic ME/CFS symptom criteria, except for the 3 month duration or when one is lacking a medical evaluation.
Exclusionary conditions
Exclusionary conditions include any active medical condition that may explain the presence of chronic fatigue, such as: untreated hypothyroidism, sleep apnea, narcolepsy, malignancies, leukemia, unresolved hepatitis, multiple sclerosis, juvenile rheumatoid arthritis, lupus erythematosus, HIV/ AIDS, severe obesity (BMI greater than 40), celiac disease, and Lyme disease.
Other exclusionary illnesses include some active psychiatric conditions that may explain the presence of chronic fatigue, such as: childhood schizophrenia or psychotic disorders, bipolar disorder, melancholic depressive disorder, active alcohol or substance abuse-except alcohol or substance abuse that has been successfully treated and resolved should not be considered exclusionary; active anorexia nervosa or bulimia nervosa (eating disorders that have been treated and resolved should not be considered exclusionary).
Non-exclusionary disorders
The child may have the presence of concomitant disorders that do not adequately explain fatigue, and are, therefore, not necessarily exclusionary. These include psychiatric diagnoses such as: school phobia, separation anxiety, anxiety disorders, somatoform disorders, and non-melancholic depressive disorders; other conditions defined primarily by symptoms that cannot be confi rmed by diagnostic laboratory tests, such as: multiple food and/or chemical sensitivity, fi bromyalgia; any condition under specifi c treatment suffi cient to alleviate all symptoms related to that condition and for which the adequacy of treatment has been documented; any condition that was treated with defi nitive therapy before development of chronic symptomatic sequelae; and any isolated and unexplained physical examination, laboratory or imaging test abnormality that is insuffi cient to strongly suggest the existence of an exclusionary condition.
Conclusion
According to the new Pediatric case defi nition, the following six classic categories include fatigue, post-exertional malaise; unrefreshing sleep, or disturbance of sleep quantity or rhythm; myofascial pain, joint pain, abdominal and/or head pain; two or more neurocognitive manifestations, and at least one symptom from two of three subcategories including autonomic manifestations, neuroendocrine manifestations or immune manifestations. This new case defi nition and assessment instrument will facilitate future research on pediatric ME/CFS and long term investigations into outcomes of the illness, helping to identify risk factors which may predict prognosis.
Many clinicians are faced with children who have unexplained fatigue and other symptoms for which exhaustive medical and psychosocial evaluations have not revealed an acceptable explanation. For any child with a chronic illness, an ongoing diagnostic evaluation that involves looking for either primary causes of fatigue and other symptoms or complications of underlying processes, is essential (Carter and Marshall, 1995) . A case defi nition is the critical beginning step in the diagnostic process. If the illness category is overly inclusive and leads to the inclusion of many who do not have this illness or does not include some with the illness, then this will make it more diffi cult to ultimately fi nd biological markers for this illness and to better understand the pathophysiology of this illness.
Having a pediatric case defi nition is a critical first step for both the diagnostic effort and subsequently will impact the types of interventions that are developed for those with this illness. Investigators have an important role to play in now using this international case defi nition to identify cases, investigate prevalence estimates, and study the pathophysiology of children and adolescents with this illness. In addition, this new case defi nition can be referenced by pediatricians, legislators, researchers, school nurses and even school teachers and staff responsible for developing and implementing Individual Education Plans. In addition to the diagnostic and educational benefi ts, the criteria can also be useful to the families dealing with pediatric ME/CFS, providing a mechanism to lend legitimacy to the child's symptoms.
